FDA Adverse Event Injury Summary report: N

VERCISE CARTESIA

MDR report key: 14837080 · Received June 27, 2022

Report

Report Number
3006630150-2022-03131
Event Type
Injury
Date Received
June 27, 2022
Date of Event
June 2, 2021
Report Date
June 27, 2022
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
NHL
UDI-DI
08714729905288
PMA / PMN Number
P150031
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NE, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

EVENT DATE: EXACT DATE UNKNOWN, EVENT OCCURRED PRIOR TO EXPLANT ON (B)(6) 2021. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS; UPN: M365DB2202450; MODEL: DB-2202-45; SERIAL: (B)(4); BATCH: 7077509. PRODUCT FAMILY: DBS-IPG-R-MRI; UPN: M365DB1200S0; MODEL: DB-1200-S; SERIAL: (B)(4); BATCH: 744531. PRODUCT FAMILY: DBS-EXTENSION; UPN: M365NM3138550; MODEL: NM-3138-55; SERIAL: (B)(4); BATCH: 7078168. PRODUCT FAMILY: DBS-EXTENSION; UPN: M365NM3138550; MODEL: NM-3138-55; SERIAL: (B)(4); BATCH: 7080604.

Description of Event or Problem · 0

IT WAS REPORTED THE PATIENT EXPERIENCED EROSION ON THE LEFT SCALP BETWEEN THE EXTENSION AND THE ELECTRODE, PROXIMAL TO THE EXTENSION INCISION OVER INTACT SKIN. CULTURES TAKEN TESTED POSITIVE FOR TWO STRAINS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA). THE PHYSICIAN ASSESSED THAT THE PATIENT HAD AN INCREASED RISK OF INFECTION DUE TO BEING ON PRADAXA FOR LUPUS ANTICOAGULATION AND HISTORY OF DEEP VEIN THROMBOSIS (DVT)/PULMONARY EMBOLISM (PE). THE PATIENT UNDERWENT A PROCEDURE WHERE THE DEEP BRAIN STIMULATION SYSTEM WAS REMOVED. THE DEVICES WERE DISCARDED BY THE FACILITY AND WERE NOT RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2017536 VERCISE CARTESIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION DB-2202-45 7077635 08714729905288

Patients

Seq Age Sex Outcome Treatment
1 72 YR Female Required Intervention